ACADIA Pharmaceuticals's market cap is currently $3.38B. The company's EPS TTM is $0.772; its P/E ratio is 26.27; ACADIA Pharmaceuticals is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 726.44M	$ 517.24M	$ 484.14M	$ 441.75M	$ 339.08M
Gross Profit	$ 680.71M	$ 507.07M	$ 465.00M	$ 421.20M	$ 319.48M
Operating Income	$ -73.38M	$ -223.60M	$ -170.44M	$ -286.59M	$ -246.54M
EBITDA	$ -67.83M	$ -221.57M	$ -167.09M	$ -286.59M	$ -243.78M
Net Income	$ -61.29M	$ -215.97M	$ -167.87M	$ -281.58M	$ -235.26M
Balance Sheet
Cash & Short-Term Investments	$ 438.87M	$ 416.82M	$ 520.71M	$ 631.96M	$ 697.43M
Total Assets	$ 748.96M	$ 587.81M	$ 700.12M	$ 782.62M	$ 783.18M
Total Debt	$ 57.20M	$ 62.00M	$ 56.13M	$ 44.46M	$ 6.36M
Net Debt	$ -131.45M	$ -52.85M	$ -91.31M	$ -281.57M	$ -183.32M
Total Liabilities	$ 317.20M	$ 187.40M	$ 159.23M	$ 155.61M	$ 84.05M
Stockholders' Equity	$ 431.75M	$ 400.41M	$ 540.89M	$ 627.01M	$ 699.13M
Cash Flow
Free Cash Flow	$ -23.35M	$ -114.03M	$ -126.78M	$ -143.75M	$ -152.26M
Operating Cash Flow	$ 16.70M	$ -114.03M	$ -125.66M	$ -136.17M	$ -151.13M
Investing Cash Flow	$ 32.00M	$ 73.24M	$ -71.10M	$ 192.51M	$ -165.84M
Financing Cash Flow	$ 25.13M	$ 8.20M	$ 18.16M	$ 81.00M	$ 371.85M

Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

Income Statement >

ACADIA Pharmaceuticals Debt to Assets

Balance Sheet >

ACADIA Pharmaceuticals Cash Flow

Cash Flow >

ACADIA Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing